176
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The in vitro and in vivo antiviral effects of IGF1R inhibitors against respiratory syncytial virus infection

, , , , , , & show all
Received 11 Aug 2023, Accepted 18 Jan 2024, Published online: 01 Feb 2024

References

  • Adasme, M. F., Linnemann, K. L., Bolz, S. N., Kaiser, F., Salentin, S., Haupt, V. J., & Schroeder, M. (2021). PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Research, 49(W1), W530–W534. https://doi.org/10.1093/nar/gkab294
  • American Academy of Pediatrics Committee on Infectious Diseases & American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics, 134, 415–420.
  • Antonello, R. M., Canetti, D., & Riccardi, N. (2022). Daptomycin synergistic properties from in vitro and in vivo studies: A systematic review. Journal of Antimicrobial Chemotherapy, 78(1), 52–77. https://doi.org/10.1093/jac/dkac346
  • Bajinka, O., Simbilyabo, L., Tan, Y., Jabang, J., & Saleem, S. A. (2022). Lung-brain axis. Critical Reviews in Microbiology, 48(3), 257–269. https://doi.org/10.1080/1040841X.2021.1960483
  • Barrows, N. J., Campos, R. K., Powell, S. T., Prasanth, K. R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E. L., Urrabaz-Garza, R., Gao, J., Wu, P., Menon, R., Saade, G., Fernandez-Salas, I., Rossi, S. L., Vasilakis, N., Routh, A., Bradrick, S. S., & Garcia-Blanco, M. A. (2016). A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host & Microbe, 20(2), 259–270. https://doi.org/10.1016/j.chom.2016.07.004
  • Bryche, B., Frétaud, M., Saint-Albin Deliot, A., Galloux, M., Sedano, L., Langevin, C., Descamps, D., Rameix-Welti, M.-A., Eléouët, J.-F., Le Goffic, R., & Meunier, N. (2020). Respiratory syncytial virus tropism for olfactory sensory neurons in mice. Journal of Neurochemistry, 155(2), 137–153. https://doi.org/10.1111/jnc.14936
  • Dai, P., et al. (2022). Dispersion and utilization of lipid droplets mediates respiratory syncytial virus-induced airway hyperresponsiveness. Pediatric Allergy and Immunology, 33, e13651.
  • EFSA. (2014). Scientific Opinion on the safety and efficacy of tannic acid when used as feed flavouring for all animal species. https://www.efsa.europa.eu/en/efsajournal/pub/3828
  • Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005). Respiratory syncytial virus infection in elderly and high-risk adults. New England Journal of Medicine, 352(17), 1749–1759. https://doi.org/10.1056/NEJMoa043951
  • Fang, K., Sun, M., Leng, Z., Chu, Y., Zhao, Z., Li, Z., Zhang, Y., Xu, A., Zhang, Z., Zhang, L., Chen, T., & Xu, M. (2023). Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia. Journal of Experimental & Clinical Cancer Research, 42(1), 73. https://doi.org/10.1186/s13046-023-02623-2
  • Feldman, R. G., Antonelli-Incalzi, R., Steenackers, K., Lee, D.-G., Papi, A., Ison, M. G., Fissette, L., David, M.-P., Maréchal, C., Van der Wielen, M., Kostanyan, L., & Hulstrøm, V, AReSVi-006 Study Group. (2023). Respiratory syncytial virus prefusion F protein vaccine is efficacious in older adults with underlying medical conditions. Clinical Infectious Diseases, ciad471 https://doi.org/10.1093/cid/ciad471
  • GBD 2016 Lower Respiratory Infections Collaborators. (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Infectious Diseases, 18(11), 1191–1210. https://doi.org/10.1016/S1473-3099(18)30310-4
  • Girnita, L., Worrall, C., Takahashi, S.-I., Seregard, S., & Girnita, A. (2014). Something old, something new and something borrowed: Emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cellular and Molecular Life Sciences, 71(13), 2403–2427. https://doi.org/10.1007/s00018-013-1514-y
  • Griffiths, C. D., Bilawchuk, L. M., McDonough, J. E., Jamieson, K. C., Elawar, F., Cen, Y., Duan, W., Lin, C., Song, H., Casanova, J.-L., Ogg, S., Jensen, L. D., Thienpont, B., Kumar, A., Hobman, T. C., Proud, D., Moraes, T. J., & Marchant, D. J. (2020). IGF1R is an entry receptor for respiratory syncytial virus. Nature, 2020,583(7817), 615–619. https://doi.org/10.1038/s41586-020-2369-7
  • Griffiths, C., Drews, S. J., & Marchant, D. J. (2017). Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clinical Microbiology Reviews, 30(1), 277–319. https://doi.org/10.1128/CMR.00010-16
  • Jentzsch, V., Osipenko, L., Scannell, J. W., & Hickman, J. A. (2023). Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors. JAMA Network Open, 6(7), e2324977. https://doi.org/10.1001/jamanetworkopen.2023.24977
  • Jiménez, J., Doerr, S., Martínez-Rosell, G., Rose, A. S., & De Fabritiis, G. (2017). DeepSite: Protein-binding site predictor using 3D-convolutional neural networks. Bioinformatics (Oxford, England), 33(19), 3036–3042. https://doi.org/10.1093/bioinformatics/btx350
  • Kaczmarek, B. (2020). Tannic acid with antiviral and antibacterial activity as A promising component of biomaterials: A minireview. Materials (Basel, Switzerland), 13(14), 3224. https://doi.org/10.3390/ma13143224
  • Kumar, D., Broor, S., & Rajala, M. S. (2016). Interaction of host nucleolin with influenza A virus nucleoprotein in the early phase of infection limits the late viral gene expression. PLoS One, 11(10), e0164146. https://doi.org/10.1371/journal.pone.0164146
  • Melgar, M., Britton, A., Roper, L. E., Talbot, H. K., Long, S. S., Kotton, C. N., & Havers, F. P. (2023). Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR. Morbidity and Mortality Weekly Report, 72(29), 793–801. https://doi.org/10.15585/mmwr.mm7229a4
  • Osher, E., & Macaulay, V. M. (2019). Therapeutic targeting of the IGF axis. Cells, 8(8), 895. https://doi.org/10.3390/cells8080895
  • Pneumonia Etiology Research for Child Health (PERCH) Study Group. (2019). Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: The PERCH multi-country case-control study. Lancet (London, England), 394(10200), 757–779.
  • Ruan, P., Wang, S., Yi, P., Yang, M., Chen, Y., & Yang, M. (2023). Identification of the potential TLR7 antagonists by virtual screening and experimental validation. Molecular Diversity. Online ahead of print. https://doi.org/10.1007/s11030-023-10660-4
  • Shi, T., McAllister, D. A., O'Brien, K. L., Simoes, E. A. F., Madhi, S. A., Gessner, B. D., Polack, F. P., Balsells, E., Acacio, S., Aguayo, C., Alassani, I., Ali, A., Antonio, M., Awasthi, S., Awori, J. O., Azziz-Baumgartner, E., Baggett, H. C., Baillie, V. L., Balmaseda, A., … Nair, H, RSV Global Epidemiology Network. (2017). Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study. Lancet (London, England), 390(10098), 946–958. https://doi.org/10.1016/S0140-6736(17)30938-8
  • Simões, E. A. F., Bont, L., Manzoni, P., Fauroux, B., Paes, B., Figueras-Aloy, J., Checchia, P. A., & Carbonell-Estrany, X. (2018). Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children. Infectious Diseases and Therapy, 7(1), 87–120. https://doi.org/10.1007/s40121-018-0188-z
  • Sp, N., Kang, D. Y., Kim, D. H., Yoo, J.-S., Jo, E. S., Rugamba, A., Jang, K.-J., & Yang, Y. M. (2020). Tannic acid inhibits non-small cell lung cancer (NSCLC) stemness by inducing G0/G1 cell cycle arrest and intrinsic apoptosis. Anticancer Research, 40(6), 3209–3220. https://doi.org/10.21873/anticanres.14302
  • Tian, P., Wang, Y., Liu, H., Yang, Y., Wu, X., Wei, H., & Chen, T. (2019). Preparation and evaluation of the fully humanized monoclonal antibody GD-mAb against respiratory syncytial virus. Frontiers in Cellular and Infection Microbiology, 9, 275. https://doi.org/10.3389/fcimb.2019.00275
  • Uchiumi, F., Hatano, T., Ito, H., Yoshida, T., & Tanuma, S. (2003). Transcriptional suppression of the HIV promoter by natural compounds. Antiviral Research, 58(1), 89–98. https://doi.org/10.1016/s0166-3542(02)00186-9
  • Utatsu, K., Motoyama, K., Nakamura, T., Onodera, R., & Higashi, T. (2023). Tannic acid-based sustained-release system for protein drugs. International Journal of Pharmaceutics, 643, 123229. https://doi.org/10.1016/j.ijpharm.2023.123229
  • Vouillamoz, J., Entenza, J. M., Giddey, M., Fischetti, V. A., Moreillon, P., & Resch, G. (2013). Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. International Journal of Antimicrobial Agents, 42(5), 416–421. https://doi.org/10.1016/j.ijantimicag.2013.06.020
  • Wasko, J. A., Dietrich, E., & Davis, K. (2019). Risk of daptomycin-associated myopathy with concomitant statin use. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 69(3), 558–559. https://doi.org/10.1093/cid/ciy1097
  • Winiarska-Mieczan, A., Muszyński, S., Tomaszewska, E., Kwiecień, M., Donaldson, J., Tomczyk-Warunek, A., & Blicharski, T. (2023). The impact of tannic acid consumption on bone mineralization. Metabolites, 13(10), 1072. https://doi.org/10.3390/metabo13101072
  • Xing, Y., & Proesmans, M. (2019). New therapies for acute RSV infections: Where are we? European Journal of Pediatrics, 178(2), 131–138. https://doi.org/10.1007/s00431-018-03310-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.